Literature DB >> 17634897

Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl.

Florian Daxboeck1, Bernhard Eisl, Christofer Burghuber, Mazda Memarsadeghi, Ojan Assadian, Gerold Stanek.   

Abstract

A case of fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl is reported. On hospital day 9, the antibody titer to M. pneumoniae was 1:512 in the complement fixation test and 1:5120 in the microparticle agglutination assay. After five weeks in the intensive care unit, the patient died from necrotizing hemorrhagic pneumonia with multi-organ failure. No significant superinfections occurred during ICU treatment. Corticosteroids (hospital day 8 onward) did not influence the course of the disease. It is noteworthy that, as in some previously reported cases, the clinical state deteriorated during presumably adequate antibiotic treatment (2 days before admission onward), and despite documented eradication of the pathogen from the respiratory tract (PCR from bronchoalveolar fluid on hospital day 22 was negative). However, the illness had lasted for several days before admission to the hospital, therefore the potentially beneficial effect of antibiotic treatment at an early stage of the disease cannot be assessed. Clearly, in default of other treatment options, correct diagnosis and early treatment of mycoplasma community-acquired pneumonia seems mandatory. This is the third case of fatal mycoplasma pneumonia reported from Austria in recent years, making this topic worthy of further scientific attention.

Entities:  

Mesh:

Year:  2007        PMID: 17634897      PMCID: PMC7102288          DOI: 10.1007/s00508-007-0810-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  34 in total

1.  Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment.

Authors:  M Radisic; A Torn; P Gutierrez; H A Defranchi; P Pardo
Journal:  Clin Infect Dis       Date:  2000-12       Impact factor: 9.079

2.  An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna.

Authors:  Florian Daxboeck; Claudia C Bauer; Ojan Assadian; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

3.  Bronchiolitis obliterans and Mycoplasma pneumonia.

Authors:  M B Prabhu; D Barber; D W Cockcroft
Journal:  Respir Med       Date:  1991-11       Impact factor: 3.415

Review 4.  Laboratory diagnosis of Mycoplasma pneumoniae infection.

Authors:  F Daxboeck; R Krause; C Wenisch
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

5.  Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection.

Authors:  J M Llibre; A Urban; E Garcia; M A Carrasco; C Murcia
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

6.  Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection.

Authors:  H P Van Bever; J W Van Doorn; H E Demey
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

7.  Fulminant Mycoplasma pneumoniae pneumonia with marked elevation of serum soluble interleukin-2 receptor.

Authors:  S Ito; Y Abe; K Kinomoto; T Saitoh; T Kato; Y Kohli; M Kuriyama; T Sakai; T Ishizaki
Journal:  Intern Med       Date:  1995-05       Impact factor: 1.271

8.  Mycoplasma pneumoniae pneumonia in a mouse model.

Authors:  L Wubbel; H S Jafri; K Olsen; S Shelton; B Barton Rogers; G Gambill; P Patel; E Keyser; G Cassell; G H McCracken
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

Review 9.  Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of three cases and literature review.

Authors:  E D Chan; T Kalayanamit; D A Lynch; R Tuder; P Arndt; R Winn; M I Schwarz
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

View more
  7 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Fulminant Mycoplasma Infection Requiring ECMO in a Previously Healthy Child: Case Report and Review.

Authors:  Catherine S Heith; Janet R Hume; Marie E Steiner; Gwenyth A Fischer
Journal:  J Pediatr Intensive Care       Date:  2017-12-18

3.  [Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].

Authors:  Herbert Kurz; Hubert Göpfrich
Journal:  Wien Med Wochenschr       Date:  2010-10-25

4.  Identification of an N-terminal 27 kDa fragment of Mycoplasma pneumoniae P116 protein as specific immunogen in M. pneumoniae infections.

Authors:  Irum Tabassum; Rama Chaudhry; Bishwanath Kumar Chourasia; Pawan Malhotra
Journal:  BMC Infect Dis       Date:  2010-12-13       Impact factor: 3.090

5.  Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients.

Authors:  Jin-Rong Liu; Jie Lu; Fang Dong; Hui-Min Li; Hui Liu; Xiao-Lei Tang; Yong-Li Guo; Shun-Ying Zhao
Journal:  Front Pediatr       Date:  2018-10-26       Impact factor: 3.418

6.  Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers.

Authors:  Lin Ding; Yu Zhao; Xuyan Li; Rui Wang; Ying Li; Xiao Tang; Bing Sun; Hangyong He
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

7.  Typical or atypical pneumonia and severe acute respiratory symptoms in PICU.

Authors:  Kam Lun Hon; Agnes S Y Leung; Kam Lau Cheung; Antony C Fu; Winnie Chiu Wing Chu; Margaret Ip; Paul K S Chan
Journal:  Clin Respir J       Date:  2014-06-09       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.